Your Health, Our Priority.

Crohn's disease (CD) is a complex and debilitating disease that significantly affects people's lives. It causes inflammation in the gastrointestinal tract, which can lead to fibrosis (an excessive build-up of scar tissue in the intestinal wall).

There are many approved treatments for CD. But unfortunately, they don't always work for everyone. Which is why we're conducting a clinical study to see if an investigational medicine that targets not only inflammation, but also fibrosis, could improve the symptoms and quality of life of people living with CD.

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers (sores) in the lining of the colon (large intestine). Those living with ulcerative colitis (UC) may experience abdominal pain, diarrhea with blood or pus (mucus) and rectal bleeding and pain. 

Qualified participants will receive financial

compensation for the completion of study

related activities.

Based on your answers to the pre-screening questions, you may be eligible for this clinical trial!

A clinical research study is being conducted in Miami to investigate the effect of an FDA approved weight loss drug on the occurrence

of heart-related events, such as heart attack and stroke. For this study, the study team is looking for people who have a history of heart conditions or have certain risk factors for heart disease.

Qualified participants will receive financial

compensation for the completion of study

related activities.

Do you think you might be interested in participating?